<b>Gapping up <br/>In reaction to strong earnings/guidance:</b><br/>OTIC +116.1%, (also reports positive results from AVERTS-2 Phase 3 Trial of OTIVIDEX), CVO +49.3%, (also awarded 2020 US Census printing and mailing contract), CMLS +43.3%, ROKU +31.1%, VKTX +20%, KNDI +15.6%, BVSN +15%, PRGO +13.8%, XRF +13%, CWH +12%, BRS +11.7%, OSTK +11.5%, (also issues warrants to purchase up to a combined aggregate of 3,722,188 shares of common stock to two purchasers in privately negotiated transactions, for an aggregate purchase price of $6.6 mln), SEDG +11.1%, COLL +10.8%, QUIK +10.5%, COTY +10.1%, ARLZ +9.3%, NOG +8.3%, PERI +8.3%, GDS +8%, EGAN +7.9%, ALQA +7.9%, PRTY +7.7%, FRSH +6.7%, GSVC +6.6%, IOTS +6.5%, KGC +5.5%, SND +5.4%, ODP +5.3%, KRO +5.1%, TTEK +5%, FLO +4.7%, AEG +4.6%, CAPR +3.9%, SLF +3.8%, SVM +3.5%, MGA +3.5%, RNG +3.1%, TWLO +3.1%, QTRH +3.1%, RUN +2.7%, APU +2.7%, MFC +2.6%, BRKS +2.2%, WRD +2%, TRTN +1.9%, ALDW +1.9%, (Delek US Holdings acquires remaining 18.4% of outstanding shares of Alon USA (ALDW) at fixed ratio of 0.49), QBAK +1.7%, MDT +1.5%, PSEC +1.2%, CPA +1.1%, CPRX +1%, TROX +1%, IMOS +1%, UVE +0.9%, NBRV +0.9%, MIME +0.8%, HIMX +0.8%, VEON +0.8%, TTM +0.8%, NVEE +0.7%, AZN +0.7%<br/><b>Other news:</b><br/>SAGE +31.2% (announces positive top-line results from two Phase 3 clinical trials with its proprietary i.v. formulation of brexanolone)<br/>MRNS +20.3% (following positive postpartum depression data from Sage Therapeutics)<br/>IDRA +6.2% (presents Clinical Data Update from Ongoing IMO-2125 Development Program)<br/>PBMD +5.1% ( to present new data from TACTI-mel Ph I clinical trial in Australia investigating use of eftilagimod alpha in combination with pembrolizumab (KEYTRUDA) in unresectable or metastatic melanoma patients)<br/>CALI +4.9% (cont strength)<br/><b>Analyst comments:</b><br/>TMUS +1.3% (upgraded to Buy from Hold at Deutsche Bank)<br/>NTAP +1.3% (upgraded to Overweight from Underweight at Barclays)<br/>ALNY +1% (upgraded to Overweight from Neutral at JP Morgan)<br/>NNN +0.8% (upgraded to Neutral from Sell at UBS)<br/><b>Gapping down<br/>In reaction to disappointing earnings/guidance:</b><br/>VSTO -30.5%, SNES -23.2%, (also plans to offer Common Stock and Warrants to purchase Common Stock and filed for offering of 2.5 mln shares common stock and warrants to purchase 625K shares of common stock ), MEET -21.4%, MHLD -16.7%, OPK -16%, INFN -11.6%, (also announces restructuring plan ), QHC -11.1%, EPC -10.3%, SRCL -9.7%, KSS -9.5%, BW -9.2%, (also plans to pursue strategic alternatives for 2 business lines), CTL -8.4%, PEGA -8.3%, ALRM -7%, JE -5.6%, ELF -5.6%, HOLX -5.2%, BEDU -5.1%, SQBG -5.1%, CSIQ -4.9%, AEZS -4.7%, EKSO -4.6%, HDSN -4.4%, COGT -4.4%, WATT -4.3%, AKAO -4.1%, FPH -4.1%, INO -3.9%, MNST -3.6%, JCI -3.6%, RLJ -3.5%, FGEN -3.3%, INCR -3.3%, NGG -3.2%, TLP -3.1%, (also entered agreement to acquire the Martinez Terminal and Richmond Terminal for $275 mln from an affiliate of Plains All American Pipeline), AFSI -2.9%, SPTN -2.8%, VIVE -2.6%, OSG -2.4%, ALB -2.1%, SPNS -2.1%, DOX -2%, ANGI -2%, CODI -2%, KIDS -2%, SQ -1.9%, TDG -1.7%, CBAY -1.6%, FOXA -1.2%, CUI -1.1%, DIN -1%, PAAS -0.9%, BLDR -0.9%, DHI -0.9%<br/><b>Other news:</b><br/>JRVR -8.4% (commences 3 mln common stock offering by selling shareholders)<br/>SRCI -7.8% (SRC Energy announces acquisition of over 30,000 acres from Noble Energy; also intends to offer for sale 35 mln shares of common stock in an underwritten public offering and intends to make private offering of $550 mln of senior unsecured notes due November 2025)<br/>CCJ -7.4% (Cameco to suspend production from McArthur River and Key Lake ops, reduces dividend; will continue to evaluate optimal mix of sources of uranium supply)<br/>TMHC -4.6% (commences 10 mln common stock offering )<br/>CADE -3.2% (prices secondary offering of 9.5 mln shares of common stock at $22.00 per share)<br/>TLP -3.1% (Transmontaigne Partners has entered into an agreement to acquire the Martinez Terminal and Richmond Terminal for $275 mln from an affiliate of Plains All American Pipeline)<br/>BFAM -3.1% (Bright Horizons announces 4 mln share secondary offering by holders including its CEO; Company intends to repurchase 1 mln shares)<br/>EBAY -1.9% (may be related to Saudi Prince Al-Waleed bin Talal arrest, as it is listed as one of his holdings)<br/>QSR -0.8% (indicated lower following block trade pricing)<br/>UAL -0.7% (October traffic +1.7%; reaffirms Q4 unit revenue)<br/>SNDR -0.5% (indicated lower following block trade pricing)<br/><b>Analyst comments:</b><br/>ERIC -2.9% (downgraded to Neutral from Buy at Citigroup)<br/>SNAP -2.1% (downgraded to Underweight from Equal-Weight at Morgan Stanley)<br/>SQ -1.9% (downgraded to Neutral from Buy at Citigroup)<br/>PFSW -1.9% (downgraded to Hold from Buy at Canaccord Genuity)<br/><br/>Briefing.com